piromelatine (Neu P11) / Neurim  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
piromelatine (Neu P11) / Neurim
NCT01489969: Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients

Completed
2
137
US
Neu-P11, Melatonin agonist
Neurim Pharmaceuticals Ltd.
Primary Insomnia
05/12
01/13
2016-002281-31: treatment of piromelatine in patients with ocular hypertension or primary open angle glaucoma. Tratamiento con Piromelatina en pacientes con hipertensión ocular o con glaucoma primario de ángulo abierto

Completed
2
47
Europe
Piromelatine, Tablet
Neurim Pharmaceuticals (1991) Ltd., Neurim Pharmaceuticals (1991) Ltd.
ocular hypertensionprimary open angle glaucoma Hipertensión ocularGlaucoma primario de ángulo abierto, ocular hypertension primary open angle glaucoma Hipertensión ocularGlaucoma primario de ángulo abierto, Diseases [C] - Eye Diseases [C11]
 
 
ReCOGNITION, NCT02615002: Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients

Completed
2
371
US
Piromelatine, Neu-P11, Placebo, Control
Neurim Pharmaceuticals Ltd.
Alzheimer's Disease
06/19
11/19

Download Options